XML 63 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT INFORMATION
12 Months Ended
Sep. 30, 2012
SEGMENT INFORMATION

10. SEGMENT INFORMATION

We report our continuing operations in three operating segments: Fine Chemicals, Specialty Chemicals, and Other Businesses. These segments are based upon business units that offer distinct products and services, are operationally managed separately and produce products using different production methods. Segment operating income or loss includes all sales and expenses directly associated with each segment. Environmental remediation charges, corporate general and administrative costs, which consist primarily of executive, investor relations, accounting, human resources and information technology expenses, and interest are not allocated to segment operating results.

Fine Chemicals. Our Fine Chemicals segment includes the operating results of our wholly-owned subsidiaries Ampac Fine Chemicals LLC and AMPAC Fine Chemicals Texas, LLC (collectively, “AFC”). AFC is a custom manufacturer of active pharmaceutical ingredients and registered intermediates for commercial customers in the pharmaceutical industry. AFC operates in compliance with the U.S. Food and Drug Administration’s current Good Manufacturing Practices and the requirements of certain other regulatory agencies such as the European Union’s European Medicines Agency and Japan’s Pharmaceuticals and Medical Devices Agency. AFC also complies with Drug Enforcement Administration requirements related to the manufacture and sale of certain controlled substances. AFC has distinctive competencies and specialized engineering capabilities in performing chiral separations, manufacturing chemical compounds that require high containment, performing energetic chemistries at commercial scale, and manufacturing Schedule II controlled substances.

Specialty Chemicals. Our Specialty Chemicals segment manufactures and sells: (i) perchlorate chemicals, principally ammonium perchlorate, which is the predominant oxidizing agent for solid propellant rockets, booster motors and missiles used in space exploration, commercial satellite transportation and national defense programs, (ii) sodium azide, a chemical used in pharmaceutical manufacturing, and (iii) Halotron®, a series of clean fire extinguishing agents used in fire extinguishing products ranging from portable fire extinguishers to total flooding systems.

 

Other Businesses. Our Other Businesses segment contains our water treatment equipment division and real estate activities. Our water treatment equipment business markets, designs, and manufactures electrochemical On Site Hypochlorite Generation, or OSHG, systems. These systems are used in the disinfection of drinking water, control of noxious odors, and the treatment of seawater to prevent the growth of marine organisms in cooling systems. We supply our equipment to municipal, industrial and offshore customers. Our real estate activities are not material.

Our revenues are characterized by individually significant orders and relatively few customers. As a result, in any given reporting period, certain customers may account for more than ten percent of our consolidated revenues. The following table provides disclosure of the percentage of our consolidated revenues attributed to customers that exceed ten percent of the total in each of the fiscal years ended September 30:

 

  

 

 

 
     2012     2011     2010  
  

 

 

 

Fine chemicals customer

     31     23     23

Fine chemicals customer

     12    

Specialty chemicals customer

     17       17

Specialty chemicals customer

     12     24     18

The following provides financial information about our segment operations for the fiscal years ended September 30:

 

  

 

 

 
     2012     2011     2010  
  

 

 

 

Revenues:

      

Fine Chemicals

   $ 111,536      $ 89,497      $ 69,632   

Specialty Chemicals

     68,513        66,905        62,611   

Other Businesses

     5,578        4,312        6,341   
  

 

 

 

Total Revenues

   $ 185,627      $ 160,714      $ 138,584   
  

 

 

 
      

Segment Operating Income (Loss):

      

Fine Chemicals

   $ 8,678      $ (6,283   $ (7,583

Specialty Chemicals

     34,919        35,600        30,571   

Other Businesses

     (473     (1,308     (206
  

 

 

 

Total Segment Operating Income

     43,124        28,009        22,782   

Corporate Expenses

     (14,326     (14,124     (15,847

Environmental Remediation Charges

     (700     (6,000     -   
  

 

 

 

Operating Income

   $ 28,098      $ 7,885      $ 6,935   
  

 

 

 

 

  

 

 

 
     2012      2011      2010  
  

 

 

 

Depreciation and Amortization:

        

Fine Chemicals

   $ 11,914       $ 12,473       $ 12,997   

Specialty Chemicals

     1,401         1,136         1,148   

Other Businesses

     18         17         16   

Corporate

     367         432         635   
  

 

 

    

 

 

    

 

 

 

Total

   $ 13,700       $ 14,058       $ 14,796   
  

 

 

    

 

 

    

 

 

 

Capital Expenditures:

        

Fine Chemicals

   $ 7,383       $ 11,153       $ 10,614   

Specialty Chemicals

     1,353         756         1,047   

Other Businesses

     18         8         12   

Corporate

     34         14         71   
  

 

 

    

 

 

    

 

 

 

Total

   $ 8,788       $ 11,931       $ 11,744   
  

 

 

    

 

 

    

 

 

 

Assets, at year end:

        

Fine Chemicals

   $ 143,551       $ 144,003       $ 137,252   

Specialty Chemicals

     21,029         19,785         39,411   

Other Businesses

     7,302         5,064         4,395   

Corporate

     74,582         60,954         64,786   
  

 

 

    

 

 

    

 

 

 

Total

   $ 246,464       $ 229,806       $ 245,844   
  

 

 

    

 

 

    

 

 

 

All of our continuing operations are located in the United States. Export sales consist mostly of fine chemicals and water treatment equipment sales. For the year ended September 30, 2012, sales outside the U.S. represented 36% of consolidated revenues. Of this amount 17% was sold to customers in Ireland and 12% sold to customers in Belgium, with no other individual country representing more than 10%. For the year ended September 30, 2011, sales outside the U.S. represented 25% of consolidated revenues, with no individual country representing more than 10%. For the year ended September 30, 2010, sales outside the U.S. represented 15% of consolidated revenues, with no individual country representing more than 10%.